Evaluating enlicitide decanoate: first oral PCSK9 inhibitor for the treatment of adults with hypercholesterolemia

More on Lipid and ceramide metabolism

• Cumulative non-HDL cholesterol is linked to CVD risk

  Journal of Diabetes and Metabolic Disorders · 4 Oct 2026

• Martin-Hopkins LDL equation best predicts cardiovascular risk

  Circulation Population Health and Outcomes · 4 Oct 2026

• Estimated sdLDL-C predicts cardiovascular risk in Japanese adults

  Journal of Clinical Lipidology · 4 Oct 2026

• Mild caloric restriction accelerates atherosclerosis in mice

  JCI Insight · 4 Oct 2026